0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

HYALURONIDASE IN EXCRETORY UROGRAPHY

Frank Hinman Jr., M.D.
AMA Arch Surg. 1951;63(5):585. doi:10.1001/archsurg.1951.01250040599001.
Text Size: A A A
Published online

ABSTRACT

The spreading factor of Duran-Reyals, hyaluronidase, has been advocated for two clinical purposes: one, as an addition to semen perhaps to facilitate dispersion of the cumulus oophorus and increase the chances of fertilization, and, the other, as an adjunct to subcutaneous therapy to allow rapid dispersion and absorption of parenterally administered fluids.

Surgeons, and more especially urologists, appear to have failed to make use of this substance in excretory urography. Hechter, Dopkeen and Yudell reported in the Journal of Pediatrics in 1947 that hyaluronidase greatly increased the rate of absorption of hypodermoclyses and detected no toxic reactions. Toxicity is apparently absent, and the incidence of sensitivity to the commercial extract derived from the testes of bulls is as low as 0.4%. One instance of contact dermatitis has been reported.

Mention of the use of hyaluronidase to hasten the uptake of dye in excretory urography in infants has appeared in several

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();